Fundraising Fox
Dublin · Seed–Growth · 13 people tracked
Find your way into Seroba Life Sciences
Sign up to see every warm intro you have to Seroba Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Seroba Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
Source: firm website, verified Sep 27, 2026.
Team · 13 people
from the firm's website & public directories
Founder mafia
2 people who came through Seroba Life Sciences went on to found or lead other companies.
What they invest in
from 25 of 35 portfolio companiesHealthtech ×23Medical Devices ×18Biotech ×16Deep Tech ×6Hardware ×4AI & Machine Learning ×3Digital Health ×3Consumer ×1
HQs:United States×7Ireland×5Germany×2Denmark×1France×1Italy×1
Who they back
founder profiles across 12 portfolio companiesFounding team size:solo founder×42 founders×53 founders×24+ founders×1
Where their founders studiedfrom 14 founders with education data
University of Galway ×2University of Groningen ×2
What their founders studiedfrom 12 founders with field-of-study data
Engineering ×3Chemistry ×2Life Sciences ×2
Where their founders worked beforefrom 15 founders with career history
BioInnovate Ireland ×2
Investments · 35 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 42022 · 22021 · 12020 · 12019 · 42017 · 32016 · 12014 · 22011 · 121 dated
Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.
HealthtechMedical DevicesGalway, IE
Brendan Boland(Co-founder & Executive Chairperson)Gerry(Co-founder)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)
Co-investorsJohnson & Johnson Innovation – JJDCEnterprise IrelandLaunch Capital
Palliare develops medical devices for minimally invasive gastrointestinal procedures, including laparoscopy and endoscopy solutions.
HardwareHealthtechMedical DevicesOceanside, IE
John O'Dea(CEO)in
Co-investorsWestern Development Commission
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalV-Bio VenturesVertis SGRVI PartnersClaris Ventures+1 more
Alveus Therapeutics develops next-generation metabolic and obesity therapies, including its lead asset ALV-100 (in Phase 2) and a preclinical amylin pipeline of peptides, oral small molecules, and novel formats aimed at sustainable weight loss with better tolerability.
BiotechHealthtechLongevityPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)inIvan Gergel(Director)inJan Van de Bossche(Director)inGarrett Ingram(Director)Gregory Parekh(Director)
Co-investorsAndera PartnersAvego BioScience CapitalGlobal BioAccess FundJeito CapitalNew Rhein Healthcare Investors, LLCAgent Capital+2 more
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsBioGeneration VenturesThuja CapitalBGV
Caldera Medical develops surgical solutions for women's health conditions including stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids.
FemTechHealthtechMedical Devices
Co-investorsAndera PartnersBorski FundAtlantic Bridge VenturesEarlybird Venture CapitalEQT Life Sciences
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.
BiotechDeep TechHealthtechMedical DevicesLeiden, NL
Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)
Co-investorsBioGeneration VenturesBioMedPartnersForbionJeito CapitalPictet GroupAsahi Kasei Corporate Venture Capital
Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Co-investorsFund+Kurma PartnersV-Bio VenturesBpifranceGO CapitalInvus+2 more
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsBioGeneration VenturesCambridge Innovation CapitalGimvHadean VenturesBGVForbion+2 more
Deciphex develops AI-powered platforms to enhance pathology efficiency, including digital image analysis, clinical trial support, and a global network of subspecialty pathologists.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsAct Venture CapitalACT Venture CapitalClaret Capital PartnersMolten Ventures
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Harry Rowland(Executive Officer, Director)inAnthony Nunez(Founder)in
BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Co-investorsAPERTURE Venture PartnersBioventures InvestorsJumpstart VenturesLumira VenturesOSF VenturesSV Health Investors+1 more
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
John Valliant(Founder)in
Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesPivotal Life SciencesVenture OntarioYsios Capital+6 more
Labcyte developed acoustic droplet ejection ("Echo") liquid-handling instruments that use focused sound waves to transfer nanoliter-scale liquid volumes between microplates without physical contact.
BiotechSunnyvale, US
Richard Ellson(Executive Officer, Director)Tammy Cameron(Executive Officer)Mark Fischer-Colbrie(Executive Officer, Director)
BoardJoseph Smith(Director)Sandra Panem(Director)Joe Keegan(Director)
Co-investorsDBL PartnersGE VenturesJP Morgan Chase
Seroba Ventures is an investment firm focused on bringing breakthrough healthcare solutions to market and addressing unmet patient needs in the global healthcare environment.
BiotechHealthtechMedical Devices
Jeanne Bolger(Venture Partner)
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)inLiam Mullins(CTO and Co-founder)in
Co-investorsSV Health InvestorsEnterprise IrelandEQT Life Sciences
PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health.
BiotechConsumerHealthtechWellness & Fitness
Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.
BiotechHealthtechMedical DevicesCopenhagen, DK
Co-investorsCardinal PartnersM VenturesSunstone CapitalYsios CapitalForbion
Quanta develops the Quanta Dialysis System, a compact, modular hemodialysis machine designed for flexible kidney care in acute and chronic facilities.
HardwareHealthtechMedical DevicesBurbank, US
ERIC RICE(Executive Officer)JEFFREY DOIRON(Executive Officer)BLAKE GILETTE(Executive Officer)KIRK WESTWOOD(Executive Officer)
Co-investorsSeventure PartnersAccelComma Capital
Ryme Medical develops a catheter-based therapy to treat chronic obstructive pulmonary disease (COPD) by reducing airway inflammation and improving patient outcomes.
BiotechHealthtechMedical DevicesMountain View, US
Co-investorsEpidarex Capital
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more
Shorla Oncology develops pharmaceutical products to address unmet needs in oncology.
BiotechHealthtechMedical DevicesDublin, IE
Sharon Cunningham(CEO & Co-Founder)inOrlaith Ryan(CTO & Co-Founder)in
Co-investorsKurma PartnersEnterprise Ireland
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Co-investorsCambridge Innovation CapitalFast Track InitiativeM VenturesPfizer Venture InvestmentsTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.+3 more
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Luc Dochez(Chair and Founder)inJosh Mandel-Brehm(Co-Founder)in
Co-investorsDroia VenturesKurma PartnersPureos BioventuresEQT Life SciencesEurazeoIdinvest Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Agi TherapeuticsApica CardiovascularCovagen AGHeart MetabolicsINNOVO by Atlantic TherapeuticsMedLumicsNovateNovate MedicalPQ BypassShorla PharmaXention
Exits · 3
3 acquisitions · showing 2Covagen AGacq. by Johnson & JohnsonPrexton Therapeuticsacq. by Lundbeck
Portfolio news
latest coverage across their companiesAlveus Therapeutics · finsmes.com · Mar 2, 2026
Azafaros · biospace.com · May 13, 2025
Frequently asked questions
- How many investments has Seroba Life Sciences made?
- Seroba Life Sciences has 35 tracked investments, 3 of which have exited, including 1 dated in the last 24 months.
- What stage does Seroba Life Sciences invest at?
- Seroba Life Sciences invests at the Seed, Series A, Series B, Series C, Growth stages.
- What is Seroba Life Sciences's typical check size?
- Seroba Life Sciences typically writes checks of $540K – $7.6M.
- What sectors does Seroba Life Sciences focus on?
- Seroba Life Sciences focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Seroba Life Sciences located?
- Seroba Life Sciences is headquartered in Dublin, IE.
- Who does Seroba Life Sciences co-invest with?
- Seroba Life Sciences most often shares deals with Andera Partners, Kurma Partners, BioGeneration Ventures, among 54 tracked co-investors.
Media · Podcasts & interviews
featuring the teamBruno MONTANARI, Partner, SEROBA LIFE SCIENCES
IPEM · Bruno Montanari
Co-investors · 12
EQT Life Sciences (formerly LSP) is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally.
Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.
Atlantic Bridge is a global growth equity technology firm investing in technology companies across Europe and the US, with multiple funds under management and a dedicated University Bridge Fund for early-stage deeptech.
Borski Fund is a venture capital fund investing in female (co)-led startups across Western Europe and the UK, aiming to close the gender-funding gap.
OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Earlybird Venture Capital is a European venture capital investor that backs early-stage technology founders with capital, strategic support, and access to an international network.
Molten Ventures invests in European technology companies across sectors including fintech, AI, climate and quantum, with a portfolio spanning over 100 companies.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
3B Future Health Fund invests in early-stage private healthcare and biotech companies in the US, Europe and Israel that address high unmet patient needs, with a focus on oncology and rare diseases.
Claris Ventures is an early-stage life sciences venture investor that makes equity investments in biopharma companies with strong scientific evidence, providing capital and hands-on support to advance clinical development programs.
venBio is a life sciences venture capital firm that partners with industry leaders to develop novel therapeutics and technologies addressing unmet medical needs.
Karista is an early-stage European venture capital firm founded in 2001 that invests in Health, DeepTech (Space & Defense) and Digital companies, typically leading rounds from Seed to Series B+.
Firms observed investing alongside Seroba Life Sciences, from public investor directories. Shared companies are the overlap with Seroba Life Sciences's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.